Ronnda joined Aastrom Biosciences in 2006 and is responsible for the scientific direction of the company, including research, development and technical operations.  She has more than 20 years of research and product development experience and most recently was executive director, biological research at MicroIslet and vice president, scientific development at StemCells Inc.

Earlier in her career, she was senior principal scientist and director of research at Advanced Tissue Sciences and was involved in the development and approval of some of the first cell-based products approved by the FDA. She has also worked as senior director, science and technology at SRS Capital, LLC evaluating life science investments and has held positions in clinical development, drug delivery, business development and manufacturing. Ronnda holds a PhD in biochemistry from the University of Kansas, has completed postdoctoral work at the University of Michigan and received a BA in chemistry and biology from Tabor College.

For more information, please see Ronnda’s previous guest blog “From Product Candidate to Product – The Road to Commercialization in Regenerative Medicine.”